|
enfuvirtide |
|
CHEBI:608828 |
|
A synthetic 36-amino acid peptide consisting of N-acetyltyrosyl, threonyl, seryl, leucyl, isoleucyl, histidyl, seryl, leucyl, isoleucyl, α-glutamyl, α-glutamyl, seryl, glutaminyl, asparaginyl, glutaminyl, glutaminyl, α-glutamyl, lysyl, asparaginyl, α-glutamyl, α-glutamyl, α-glutamyl, leucyl, leucyl, α-glutamyl, leucyl, α-aspartyl, lysyl, tryptophyl, alanyl, seryl, leucyl, tryptophyl, asparaginyl, tryptophyl, and phenylalaninamide residues joined in sequence. An HIV fusion inhibitor, it was the first of a novel class of antiretroviral drugs used in combination therapy for the treatment of HIV-1 infection. It interferes with entry of HIV into cells by binding to the gp41 sub-unit of the viral envelope glycoprotein, so inhibiting fusion of viral and cellular membranes. |
|
 
This entity has been manually annotated by the ChEBI Team.
|
|
No supplier information found for this compound. |
|
Molfile
XML
SDF
|
|
more structures >>
|
|
|
InChI=1S/C204H301N51O64/c1- 20- 102(15) 166(253- 195(310) 137(75- 100(11) 12) 239- 200(315) 150(93- 258) 251- 190(305) 143(82- 112- 90- 215- 95- 219- 112) 248- 203(318) 167(103(16) 21- 2) 254- 196(311) 138(76- 101(13) 14) 240- 201(316) 151(94- 259) 252- 204(319) 168(105(18) 260) 255- 197(312) 139(221- 106(19) 261) 78- 108- 45- 47- 113(262) 48- 46- 108) 202(317) 233- 131(58- 68- 164(280) 281) 178(293) 228- 130(57- 67- 163(278) 279) 182(297) 250- 149(92- 257) 198(313) 232- 125(52- 62- 155(210) 266) 179(294) 245- 145(84- 157(212) 268) 191(306) 229- 124(51- 61- 154(209) 265) 175(290) 224- 122(49- 59- 152(207) 263) 173(288) 226- 126(53- 63- 159(270) 271) 176(291) 222- 120(43- 31- 33- 69- 205) 172(287) 244- 144(83- 156(211) 267) 192(307) 231- 127(54- 64- 160(272) 273) 177(292) 225- 123(50- 60- 153(208) 264) 174(289) 227- 128(55- 65- 161(274) 275) 180(295) 235- 134(72- 97(5) 6) 185(300) 237- 133(71- 96(3) 4) 184(299) 230- 129(56- 66- 162(276) 277) 181(296) 236- 135(73- 98(7) 8) 187(302) 247- 147(86- 165(282) 283) 194(309) 223- 121(44- 32- 34- 70- 206) 171(286) 241- 140(79- 109- 87- 216- 117- 40- 28- 25- 37- 114(109) 117) 183(298) 220- 104(17) 170(285) 249- 148(91- 256) 199(314) 238- 136(74- 99(9) 10) 186(301) 242- 142(81- 111- 89- 218- 119- 42- 30- 27- 39- 116(111) 119) 189(304) 246- 146(85- 158(213) 269) 193(308) 243- 141(80- 110- 88- 217- 118- 41- 29- 26- 38- 115(110) 118) 188(303) 234- 132(169(214) 284) 77- 107- 35- 23- 22- 24- 36- 107/h22- 30,35- 42,45- 48,87- 90,95- 105,120- 151,166- 168,216- 218,256- 260,262H,20- 21,31- 34,43- 44,49- 86,91- 94,205- 206H2,1- 19H3,(H2,207,263) (H2,208,264) (H2,209,265) (H2,210,266) (H2,211,267) (H2,212,268) (H2,213,269) (H2,214,284) (H,215,219) (H,220,298) (H,221,261) (H,222,291) (H,223,309) (H,224,290) (H,225,292) (H,226,288) (H,227,289) (H,228,293) (H,229,306) (H,230,299) (H,231,307) (H,232,313) (H,233,317) (H,234,303) (H,235,295) (H,236,296) (H,237,300) (H,238,314) (H,239,315) (H,240,316) (H,241,286) (H,242,301) (H,243,308) (H,244,287) (H,245,294) (H,246,304) (H,247,302) (H,248,318) (H,249,285) (H,250,297) (H,251,305) (H,252,319) (H,253,310) (H,254,311) (H,255,312) (H,270,271) (H,272,273) (H,274,275) (H,276,277) (H,278,279) (H,280,281) (H,282,283) /t102- ,103- ,104- ,105+,120- ,121- ,122- ,123- ,124- ,125- ,126- ,127- ,128- ,129- ,130- ,131- ,132- ,133- ,134- ,135- ,136- ,137- ,138- ,139- ,140- ,141- ,142- ,143- ,144- ,145- ,146- ,147- ,148- ,149- ,150- ,151- ,166- ,167- ,168- /m0/s1 |
PEASPLKKXBYDKL-FXEVSJAOSA-N |
CC[C@H] (C) [C@H] (NC(=O) [C@H] (CC(C) C) NC(=O) [C@H] (CO) NC(=O) [C@H] (Cc1cnc[nH] 1) NC(=O) [C@@H] (NC(=O) [C@H] (CC(C) C) NC(=O) [C@H] (CO) NC(=O) [C@@H] (NC(=O) [C@H] (Cc1ccc(O) cc1) NC(C) =O) [C@@H] (C) O) [C@@H] (C) CC) C(=O) N[C@@H] (CCC(O) =O) C(=O) N[C@@H] (CCC(O) =O) C(=O) N[C@@H] (CO) C(=O) N[C@@H] (CCC(N) =O) C(=O) N[C@@H] (CC(N) =O) C(=O) N[C@@H] (CCC(N) =O) C(=O) N[C@@H] (CCC(N) =O) C(=O) N[C@@H] (CCC(O) =O) C(=O) N[C@@H] (CCCCN) C(=O) N[C@@H] (CC(N) =O) C(=O) N[C@@H] (CCC(O) =O) C(=O) N[C@@H] (CCC(N) =O) C(=O) N[C@@H] (CCC(O) =O) C(=O) N[C@@H] (CC(C) C) C(=O) N[C@@H] (CC(C) C) C(=O) N[C@@H] (CCC(O) =O) C(=O) N[C@@H] (CC(C) C) C(=O) N[C@@H] (CC(O) =O) C(=O) N[C@@H] (CCCCN) C(=O) N[C@@H] (Cc1c[nH] c2ccccc12) C(=O) N[C@@H] (C) C(=O) N[C@@H] (CO) C(=O) N[C@@H] (CC(C) C) C(=O) N[C@@H] (Cc1c[nH] c2ccccc12) C(=O) N[C@@H] (CC(N) =O) C(=O) N[C@@H] (Cc1c[nH] c2ccccc12) C(=O) N[C@@H] (Cc1ccccc1) C(N) =O |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
HIV fusion inhibitor
A drug which interferes with the binding, fusion and entry of an HIV virion to a human cell. By blocking this step in HIV's replication cycle, such agents slow the progression from HIV infection to AIDS.
|
|
HIV fusion inhibitor
A drug which interferes with the binding, fusion and entry of an HIV virion to a human cell. By blocking this step in HIV's replication cycle, such agents slow the progression from HIV infection to AIDS.
|
|
View more via ChEBI Ontology
N- acetyl- L- tyrosyl- L- threonyl- L- seryl- L- leucyl- L- isoleucyl- L- histidyl- L- seryl- L- leucyl- L- isoleucyl- L- α- glutamyl- L- α- glutamyl- L- seryl- L- glutaminyl- L- asparaginyl- L- glutaminyl- L- glutaminyl- L- α- glutamyl- L- lysyl- L- asparaginyl- L- α- glutamyl- L- α- glutamyl- L- α- glutamyl- L- leucyl- L- leucyl- L- α- glutamyl- L- leucyl- L- α- aspartyl- L- lysyl- L- tryptophyl- L- alanyl- L- seryl- L- leucyl- L- tryptophyl- L- asparaginyl- L- tryptophyl- L- phenylalaninamide
|
Ac-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-NH2
|
ChEBI
|
AcTyrThrSerLeuIleHisSerLeuIleGluGluSerGlnAsnGlnGlnGluLysAsnGluGlnGluLeuLeuGluLeuAspLysTrpAlaSerLeuTrpAsnTrpPheNH2
|
ChEBI
|
enfuvirtide
|
ChEMBL
|
pentafuside
|
ChemIDplus
|
T 20
|
ChemIDplus
|
11023586
|
Beilstein Registry Number
|
Beilstein
|
11360774
|
Beilstein Registry Number
|
Beilstein
|
159519-65-0
|
CAS Registry Number
|
ChemIDplus
|
8758835
|
Beilstein Registry Number
|
Beilstein
|
9384544
|
Beilstein Registry Number
|
Beilstein
|
9612670
|
Beilstein Registry Number
|
Beilstein
|
17485501
|
PubMed citation
|
ChEMBL
|
25017682
|
PubMed citation
|
Europe PMC
|
|